(Q44340927)

2 December 2017

Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice (English)

1 reference

2 December 2017

0 references

0 references

Alexis Bailey

2

0 references

author name string

Heidi M B Lesscher

1

1 reference

2 December 2017

J Peter H Burbach

3

1 reference

2 December 2017

Jan M Van Ree

4

1 reference

2 December 2017

Ian Kitchen

5

1 reference

2 December 2017

Mirjam A F M Gerrits

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

European Journal of Neuroscience

2 December 2017

1 reference

2 December 2017

17

1 reference

2 December 2017

5

1 reference

2 December 2017

1006-1012

1 reference

Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.

2 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Exploring the opioid system by gene knockout

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Pharmacotherapy of addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Regulations of opioid dependence by opioid receptor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

mu-Opposing actions of the kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic pretreatment with naltrexone facilitates acquisition of intravenous cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Chronic opioid antagonist treatment: assessment of receptor upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

Naltrexone-induced opiate receptor supersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02502.X

10.1046/J.1460-9568.2003.02502.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference